Related Experiment Videos
[Primary cardiac lymphoma: a case report].
Jun Tanaka1, Satoru Takamoto, Tomiko Ryu
1Department of Cardiology, Social Insurance General Hospital, Hyakunin-cho 3-22-1, Shinjuku-ku, Tokyo 169-0073.
Journal of Cardiology
|December 5, 2002
Summary
Primary cardiac lymphoma, a rare cancer, can cause heart failure. Prompt diagnosis and chemotherapy are crucial for effective treatment, even with relapses.
Area of Science:
- Cardiology
- Oncology
- Hematology
Background:
- Primary cardiac lymphoma is a rare malignancy with challenging diagnosis and treatment.
- Early detection is often hindered by nonspecific symptoms and diagnostic difficulties.
Observation:
- An 83-year-old woman presented with pretibial edema, later found to have a large right atrial and ventricular tumor.
- Initial transvenous biopsy was inconclusive; however, elevated soluble interleukin-2 receptor and gallium-67 uptake supported primary cardiac lymphoma.
- The tumor responded to chemotherapy but recurred in the anterior mediastinum as diffuse B-cell non-Hodgkin's lymphoma.
Findings:
- Chemotherapy led to the disappearance of the intracardiac tumor.
- The patient experienced a relapse with mediastinal involvement, requiring additional irradiation.
- Histological confirmation identified diffuse B-cell non-Hodgkin's malignant lymphoma.
Implications:
- This case highlights the importance of early diagnosis and prompt chemotherapy initiation for primary cardiac lymphoma.
- Multimodality treatment, including chemotherapy and irradiation, may be necessary for managing relapsed disease.
- Further research into optimal diagnostic and therapeutic strategies for primary cardiac lymphoma is warranted.